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Abstract
OBJECTIVE: The aim of this study was to investi-
gate the effects and safety of modified fasting ther-
apy using fermented medicinal herbs and exercise
on body weight, fat and muscle mass, and blood
chemistry in obese subjects.
METHODS: Twenty-six patients participated in a
14-day fast, during which they ingested a supple-
ment made from fermented medicinal herbs and
carbohydrates (intake: 400-600 kcal/d). The sched-
ule included 7 prefasting relief days and 14 days of
stepwise reintroduction of food. The patients also
took part in an exercise program that incorporated
Qigong, weight training, and walking exercises. The
efficacy of treatments was observed by assessing
body fat mass and muscle mass, and alanine amino-
transferase (ALT), aspartate aminotransferase (AST),
cholesterol, and triglycerides in each study period.
Specific symptoms or side effects were reported.
RESULTS: Body weight and body fat mass both de-
creased significantly by (5.16 ± 0.95) and (3.89 ±
0.79) kg (both P < 0.05), while muscle mass de-
creased by an average of (0.26 ± 0.22) kg, without
statistical significance. ALT levels were significantly
decreased (P < 0.05), while AST levels decreased
without statistical significance (P = 0.052). The lev-
els of total cholesterol and triglycerides were also
significantly decreased (both P < 0.05). There were
few adverse events except for mild dizziness, which
did not affect everyday living.
CONCLUSION: These results suggest that modified
fasting therapy using fermented medicinal herbs
and exercise could be effective and safe on obese
patients.
© 2016 JTCM.
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INTRODUCTION
Obesity is generally defined as excess body fat, and is
caused by complex interactions between the environ-
ment, genetic predisposition and personal behavior.1
World Health Organization (WHO) estimates showed
that in 2005, approximately 1.6 billion people world-
wide were overweight, and at least 400 million adults
were obese.2,3 A greater body weight (BW) is associated
with increased incidence of a number of conditions, in-
cluding diabetes mellitus, cardiovascular disease,
non-alcoholic fatty liver disease and an increased risk
of disability. Evidence suggests that even a moderate
amount of weight loss can be beneficial in terms of re-
ducing levels of some negative risk factors, such as
blood pressure.1 The initial goal of weight loss therapy
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for overweight patients is a reduction in BW and main-
taining a lower BW over the long term. Effective
weight control involves multiple techniques and strate-
gies including dietary therapy, physical activity, behav-
ior therapy, pharmacotherapy, and surgery.4 Many stud-
ies of dietary and behavioral treatments, however, have
shown that maintenance of weight loss is difficult.1
Among a variety of dietary treatments, very-low-calorie
diet (VLCD) is an effective therapeutic method to effi-
ciently reduce BW over a relatively short period of
time. The VLCD is defined as intake of 400-800 kcal/
d, and it focuses on minimizing protein loss.5 However,
low compliance rates due to side-effects such as hunger
and short durability for weight loss, are major limita-
tions of VLCD. Many experts recommend VLCD
combined with exercise or behavioral treatments as an
effective method for the management of obesity to
maintain weight loss.6-8 Recently, a new type of VLCD
that includes fermented medicinal herbs and carbohy-
drates, which is based on fasting therapy of traditional
Korean medicine, has attracted growing popularity in
Korea as an effective method for the treatment of obesi-
ty. This modified fasting therapy (MFT) reduces stress
because it satisfies basic energy demands of the essen-
tial organs (such as the brain and the heart) with carbo-
hydrates, prevents overeating by preventing hunger,
and helps maintain active bowel movements through
enzymes and probiotics.9,10 Despite the perceived advan-
tages of MFT using fermented medicinal herbs, few
clinical reports have examined this treatment.11,12
We describe the preliminary experience of the Obesity
Clinic at Kyung Hee University Korean Medical Hospi-
tal in selected cases treated with MFT using fermented
medicinal herbs combined with exercise therapy. The
aim of this retrospective study was to investigate the ef-
fects of MFT on BW, body fat mass (BFM) and mus-
cle mass (MM), and blood chemistry, and to observe
the safety of MFT in obese patients.
PARTICIPANTS ANDMETHODS
Patient eligibility
Thirty inpatients with obesity [body mass index
(BMI) ≥25 kg/m2] were treated with MFT between
March 2009 and February 2012 at the Obesity Clinic
of Kyung Hee University Korean Medicine Hospital.
All patients met the following criteria for inclusion: (a)
completed at least 7 days of prefasting, 14 days of
fasting, and 14 days of refeeding; (b) were measured at
least four times in the following ways: BW, BFM and
MM before prefasting (BP), before fasting (BF), after
fasting (AF), and after refeeding (AR); (c) had blood
chemistry measurements taken at least twice BF and
AR. We excluded the following patients: one patient
with fewer than 7 days of fasting, one patient with
fewer than four body measurements of BW, BFM and
MM, and two patients with fewer than two blood
chemistry measurements. In addition, patients who
had experienced any of the following: weight changes
greater than 3 kg within 2 months, received any
treatment for obesity in the previous 6 months, were or
might be pregnant or who had given birth during the
previous 6 months, were also excluded. Finally, 26
inpatients aged between 18 and 55 years were included
in our analysis. There were no patients with severe
cardiovascular diseases or malignant tumors that
needed aggressive treatment. The entire procedure,
effects and possible side effects of MFT and any
accompanying treatments were explained in detail to
the included patients, and written informed consent
was obtained from all patients before treatment began.
The protocol for the research project was approved by
the Institutional Review Board of Kyung Hee
University Hospital and conforms to the provisions of
the Declaration of Helsinki in 1995.
Treatment
The patients agreed to participate in a 14-day fast with
a supplement made from fermented medicinal herbs
and carbohydrates (intake: 400-600 kcal/d) following
7 prefasting relief days, which were then followed by
14 days of stepwise reintroduction of food. Patients
were hospitalized during the 14 day fasting period and
received intensive care and special monitoring by spe-
cialized practitioners. Vital signs, general condition,
specific symptoms and adverse events were checked ev-
ery 6 h. The fasting patients also participated in an ex-
ercise program including Qigong, weight training and
walking exercises for at least 1 h every day during the
entire period of MFT.
During the prefasting days, participants consumed less
than half of their usual food intake and ate a low-salt
diet mainly composed of brown rice, vegetables and
fruits. Meat, caffeine, soda and processed food as well
as drinking alcohol and smoking were prohibited dur-
ing prefasting days. On the last day of prefasting, only
three meals of porridge or a thin gruel of rice and some
fruit were permitted along with antacid and laxative
medications before retiring to bed.
During the MFT fasting period, patients were allowed
unlimited intake of mineral water, and limited intake
of 200-300 mL of the Signature supplement made of
fermented extracts of Houttuynia cordata Thunb and
Saururus chinensis Baill and probiotics twice a day
(DuolacTM7, Cellbiotech Co., Ltd., Gyunggi-do, Ko-
rea). The Signature supplement represents a heat value
of 61 kcal per 30 mL. During the fasting period, all
medications for other diseases, such as hypertension,
dyslipidemia and depression, were discontinued, except
those for thyroid diseases, which were prescribed under
consultation with a Korean medicine doctor.
Only porridge or gruel was permitted on the first day
of the refeeding period. On the second day, partici-
pants were allowed additional vegetables and fruits,
and then brown rice and meat were gradually added
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during the stepwise reintroduction of food. The basic
menu during the refeeding period was equally offered
to all patients. Thorough chewing, eating small
amounts of food, and adhering to a low-salt diet were
principles emphasized throughout the entire refeeding
period.
Measurements
Patient characteristics, medical history, clinical data,
body composition measurements (Inbody 4.0, Bio-
space, Seoul, Korea), and blood chemistry were record-
ed in patient charts. We observed the efficacy of treat-
ments by collecting data for body composition and
blood chemistry during each MFT period. Data for
body composition included BW (kg), body-mass index
(BMI, kg/m2), body-fat mass (BFM, kg), and muscle
mass (MM, kg). Blood chemistry included aspartate
aminotransferase (AST, IU/L), alanine aminotransfer-
ase (ALT, IU/L), total cholesterol (T-chol, mg/dL),
and triglycerides (TG, mg/dL). At least four different
body composition measurements (BP, BF, AF, and
AR) and two separate blood chemistry measurements
(BF and AR) were required. Changes in specific symp-
toms that appeared at any time during the study peri-
od were reported. Continuous monitoring of partici-
pants for any adverse events and periodic assessments
of vital signs were performed to ensure safety. Partici-
pants were asked to subjectively record unexpected
events during treatment, such as mild dizziness, hun-
ger, fatigue, constipation, nausea, diarrhea, or gall-
stone, which are possible adverse effects of a VLCD
based on the guidelines of the National Institute of Di-
abetes and Digestive and Kidney Disease (NIDDK) of
the National Institutes of Health (NIH).13
Statistical analysis
Data were presented as mean ± standard deviation ( xˉ
± s). Paired t-tests and Wilcoxon signed rank tests were
conducted to evaluate the mean differences between pa-
tients both before and after MFT. Analysis of variance
was conducted to evaluate the difference of MFT in in-
ducing changes of body composition over time. Statisti-
cal significant level was P < 0.05. The statistical analy-
sis was carried out using SPSS or Windows (version
12.0; SPSS Inc., Chicago, IL, USA).
RESULTS
Baseline characteristics
At baseline, patient demographic characteristics (age,
sex, BW and BMI) were as follows. Of the 26
participating patients, 9 were male and 17 female. The
averageof age (years), BW (kg) and BMI (kg/m2) were
39 ± 9, 71.60 ± 6.55, and 28.9 ± 1.7, respectively.
When classified according to WHO guidelines, 19
patients were obese, and seven severely obese.
Body weight, fat mass and muscle mass
During the prefasting period, BW, BFM and MM sig-
nificantly decreased by (1.98 ± 0.65), (0.96 ± 0.50)
and (0.91 ± 0.26) kg, respectively (P < 0.05). During
the fasting period, BW, BFM and MM decreased by
(2.99 ± 0.82), (1.48±0.57) and (0.82 ± 0.35) kg, re-
spectively (P < 0.05). During the refeeding period, BW
decreased, but not significantly, by (0.19 ± 0.50) kg.
The BFM decreased to (1.46 ± 0.49) kg, while MM in-
creased by (1.47 ± 0.36) kg during the refeeding peri-
od, and both changes were significant (both P < 0.05).
During the entire MFT period, BW and BFM de-
creased significantly by (5.16 ± 0.95) and (3.89 ±
0.79) kg (both P < 0.05), while MM decreased, but
not significantly, by (0.26 ± 0.22) kg. The F values
over time for BW, BFM and MM were 102.119,
71.892 and 64.576, respectively (all P < 0.05) (Table
1).
Blood chemistry
We also investigated the efficacy of treatments by
analyzing blood samples for AST, ALT (IU/L), T-chol,
and TG (mg/dL) of patients during the BF and AR
periods. The AST level decreased from (24.1 ± 4.3) to
(19.5 ± 2.9) IU/L, without statistical significance (Z =
－1.942, P = 0.052), while the ALT level significantly
decreased from (30.1 ± 12.8) to (20.5 ± 4.12) IU/L
(Z = －2.125, P < 0.05). The levels of T-chol and TG
were both significantly decreased from (181.5 ± 17.4) to
(156.0 ± 12.7) mg/dL (Z =－3.738, P < 0.05) and from
(103.9 ± 22.8) to (90.5 ± 18.4) mg/dL (Z = －1.999,
P < 0.05), respectively. (Table 2).
Specific symptoms and adverse events
Among the 26 patients included in this study, 10 were
followed-up for 1 month after MFT and continued to
show positive results regarding changes in BW, BFM
Item
Body weight (kg)
Body fat mass (kg)
Muscle mass (kg)
Baseline
(before prefasting)
71.6±6.6
24.6±4.3
25.7±2.6
1 week
(before fasting)
69.6±6.2a
23.7±4.1a
24.8±2.5b
3 weeks
(after fasting)
66.6±5.8a
22.2±3.7a
23.9±2.4b
5 weeks
(after refeeding)
66.4±5.9
20.7±3.7a
25.4±2.5b
F value
102.119c
71.892c
64.576c
Table 1 Changes of body weight, fat mass and muscle mass after modified fasting therapy using fermented medicinal herbs ( xˉ ±
s)
Notes: statistical significance was evaluated by paired sample t-test (aP < 0.05). Statistical significance was evaluated by Wilcoxon signed
ranks test (bP < 0.05). Statistical significance was evaluated by repeated measures analysis of varince (cP < 0.05).
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and MM. Three patients with insomnia, four patients
with lower back pain and one patient with facial acne
at the beginning of the study experienced improve-
ments after MFT. Patients with insomnia withdrew
from narcotic medication for the duration of the study.
Although drugs for other diseases such as
hypertension, dyslipidemia or depression were dis-
continued during the fasting period, no specific related
problems were noted in any patient. During the entire
period of MFT, five minor adverse events were
reported, but these did not affect everyday living.
Almost all of these events appeared during the fasting
period and disappeared after a few days. No serious
adverse events were reported.
DISCUSSION
Fasting therapy is a therapeutic method which aims to
promote the self-healing power by eliminating
poisonous and waste matter from the body, and at the
same time utilize the energy stored in the body without
interruption of the external energy supply. Historically,
the reasons to fast have involved both religious and / or
medical issues. Fasting was an established treatment
method since the time of Hippocrates, and was then
developed in the United States at the beginning of the
twentieth century by the physicians Tanner, Dewey,
and Hazzard. Their method of fasting consisted of
water and tea, supported by enemas and physical
exercise.14 Based on the works of the physicians
Buchinger, Bircher-Benner, and Mayr, medical fasting
attracted a growing number of patients in Europe from
the 1950s onwards. Buchinger's method of fasting
included free intake of mineral water and limited
intake of fruit juice (< 350 kcal/d), which substantially
reduces protein loss by gluconeogenesis.15,16 The fasting
cure is further accompanied by bowel cleansing,
exercise, nutritional advice, and mind/body
techniques. Recently, MFT has attracted growing
popularity as a self-care method for health and
particularly for initiating lifestyle modification.17
The treatment method with fermented medicinal
herbs used in this study is based on an MFT of tradi-
tional Korean medicine, which is widely used for the
management of obesity in Korea.9-12 It includes the free
intake of mineral water and limited intake of a supple-
ment made from fermented medicinal herbs and carbo-
hydrates (intake: 400-600 kcal/d). This method is dif-
ferent from water fasting in that patients receive the
VLCD in addition to water. A special feature of this
VLCD is that it supplies basic energy sources for essen-
tial organs (such as the brain and the heart) in the
form of easily absorbed carbohydrates from fermenta-
tion, and it is combined with an exercise program. Dur-
ing the fasting period, gluconeogenesis takes place
through an acute stress response to obtain energy need-
ed for activity.15,16 The MFT slows the process of gluco-
neogenesis and reduces the loss of muscular mass and
the drop in basal metabolic rate induced by the loss of
lean body mass.
The many advantages of the MFT using fermented me-
dicinal herbs include the reduction of stress on essen-
tial organs, preventing hunger, facilitating physical ac-
tivities during the fasting period, and helping bowel re-
covery by supplying enzymes and probiotics.9,10 Howev-
er, few clinical studies on this form of MFT have been
reported to date.11,12 One is a retrospective observation-
al study which concluded that BW and BMI decreased
significantly while MM and basal metabolic rate did
not show any significant decrease.12 These results are
consistent with our study but it did not assess changes
in blood chemistry. The other study is a case report
with similar results to ours, but it cannot be general-
ized because of the limitations of a case report.11
Our observational study of a clinical case series has sev-
eral meaningful results. First, BFM decreased an aver-
age of (1.46 ± 0.49) kg, while MM increased (1.47 ±
0.36) kg during the refeeding period (P < 0.05). Dur-
ing the entire study period, BW and BFM decreased
(5.16 ± 0.95) and (3.89 ± 0.79) kg (P < 0.05), respec-
tively, while MM decreased (0.26 ± 0.22) kg, which
was not statistically significant. These results are differ-
ent from the study by Leibel et al,18 which found that
the loss of fat-free mass comprised a large proportion
of weight loss when energy intake was extremely re-
stricted. A report on VLCDs that supply enough pro-
tein (> 50 g) to minimize the loss of fat-free mass indi-
cated that the loss of BFM was three times greater than
that of fat-free mass.9 In our study of the MFT, the loss
of BFM was greater than three times that of the fat-free
mass. When compared with the loss in conventional
fasting therapy, which includes four distinct time peri-
ods to decrease the side-effects of fasting, the loss of
MM was more than that of BFM, resulting in a de-
Item
AST (IU/L)
ALT (IU/L)
Total cholesterol (mg/dL)
Triglycerides (mg/dL)
Before fasting
24.1±4.3
30.1±12.8
181.5±17.4
103.9±22.8
After refeeding
19.6±2.9
20.5±4.2
156.0±12.7
90.5±18.4
Z score
－1.942
－2.125a
－3.738a
－1.999a
Table 2 Changes of blood chemistry after modified fasting therapy using fermented medicinal herbs ( xˉ ± s)
Notes: AST: aspartate aminotransferase; ALT: alanine aminotransferase. Statistical significance was evaluated by Wilcoxon signed ranks test
(aP < 0.05).
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crease of basal metabolic rate. Therefore, our study's re-
sults have important implications.
The level of ALT also significantly decreased, while the
level of AST decreased but was not statistically signifi-
cant (P = 0.052). In particular, patients with abnormal
ranges of AST and ALT levels before the study had re-
covered to the normal range. Levels of AST and ALT
usually increase when hepatocytes are injured or MM
is decreased during fasting therapy, but these levels de-
crease during other treatment programs for weight loss,
such as diet therapy and exercise therapy, which supply
a certain amount of calories.10,19-21 Considering that sev-
eral studies of the relationship between conventional
fasting therapy and the levels of AST and ALT showed
a significant increase of AST and ALT, the results of
our study are noteworthy.
The levels of both T-chol and TG were also significant-
ly decreased. T-chol levels usually increase during fast-
ing periods through continuous biosynthesis and a de-
crease of emission and isolation from storage organs to
blood, while they decrease during the AR period and
the entire period. The results of our study coincide
with those of previous studies.22,23
Existing studies reveal different opinions on TG levels.
Some indicate that TG levels increase in response to
the increase of free fatty acids induced from the decom-
position of adipose tissue, which regulates the metabo-
lism of TG. Others report that TG decreases as a result
of the increase of utilization in the liver and peripheral
organs as a form of alternative energy, which is in ac-
cordance with the results of our study.22 The change of
TG levels is likely to be related to the changes of insu-
lin and glucagon levels as well as to the response of the
sympathetic nervous system, but further study is need-
ed.23
During the entire MFT period, no serious adverse
events were reported with the exception of common
complications such as mild dizziness or hunger. How-
ever, these symptoms did not have effects on everyday
living. The patients that reported insomnia, lower back
pain, and facial acne experienced improvements in
these symptoms after MFT. Although medications for
other diseases such as hypertension, dyslipidemia or de-
pression were discontinued during the fasting period,
no specific problems were recorded by the Korean med-
ical doctors overseeing the treatments. These observa-
tions suggest that MFT results in both weight loss and
improvements of clinical manifestations in some diseas-
es. The results of this study were likely to be due to the
maintenance of the basal metabolic rate and to im-
provements related to the modification of lifestyle with
the gradual introduction of physical activities.
This study has a number of limitations, including the
small sample size and the retrospective and observation-
al study design that lowered the reliability. Only two
types of blood chemistry measurements, BF and AR,
were performed, which did not allow a detailed analy-
sis of each period of MFT. Blood chemistry can vary
according to the study period; for example, the level of
T-chol usually increases during the fasting period
through continuous biosynthesis, the decrease of emis-
sion and isolation from the storage organ to blood,
while it decreases during the refeeding period and the
entire period. Thus, more frequent measurements of
blood chemistry were required. Further analyses of
blood chemistry indicators will be needed in the fu-
ture. Among the 26 patients included in our sample,
10 had been followed up for one month, and they con-
tinued to show positive results in BW, BFM and MM.
Considering that the durability of a treatment method
is the most important factor in the treatment for obesi-
ty, follow-up for longer periods of time is necessary.
This study investigated the effectiveness and safety of
the MFT using fermented medicinal herbs by assessing
changes of BW, BFM and MM and blood chemistry as
a retrospective observational method. Given the find-
ing that patients with MFT using fermented medicinal
herbs and exercise had a statistically significant im-
provement, further investigation may be warranted.
However, the limitation of a retrospective observation-
al study raises questions about relative contributions of
this form of MFT compared with other treatment
tools for obesity. Therefore, additional studies with a
greater sample size and a more reliable study design
will be necessary.
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